Desirability Team Validation Report
1. Executive Summary
Overview of Findings: The validation process underscored the significant potential and relevance
of the proposed solution to improve billing transparency in the healthcare system. Our exploration
highlighted the presence of compelling pain points related to opaque billing practices, especially
within community and regional health systems.
Key Insights and Assessment: The target market shows a high degree of interest due to
regulatory pressures and patient demands for clarity in billing processes. Partnership with JRAH
and focusing on niche areas within health systems is likely to create a competitive advantage.
High-level Recommendations: Focus efforts on qualitative user feedback through the JRAH
partnership, enhance differentiation by highlighting emotional and financial benefits, and prepare
for strategic scaling and investor engagement.
2. Validation Criteria
Evaluation Metrics Used: Our evaluation used a combination of customer desirability, market
alignment, competitive analysis, and investment appeal metrics.
Aspects Analyzed:
Customer desirability through problem relevance and target segment fit.
Differentiation amidst existing solutions.
Partnership benefits with local health systems.
Market trends influencing billing transparency.
Financial ROI potential for stakeholders.
Supporting Data Sources: Market research included behavioral studies on patient billing
confusion, industry trend analyses, and competitive landscape reviews.
3. Key Debates & Challenges
Points of Disagreement: Key disagreements revolved around the optimal emphasis on regulatory
influences versus patient-driven demand, and the initial approach to solving the problemâ€”whether
to focus on immediate ROI or patient satisfaction to guide market entry.
Conflict Resolution: Suggestions to use the JRAH partnership strategically were agreed upon as
a pathway for field testing and refining approaches. Delta's focus on demonstrating investor
readiness led to including financial transparency and ethical positioning in planning.
Unresolved Issues: Ongoing analysis needed to determine the best geographical regions for
expansion post-JRAH pilot phase.
1 OF 2
4. Final Recommendations
Summary of Conclusions: The business model should capitalize on collaborations with health
systems like JRAH, emphasizing nuanced user pain points. Differentiation is key for market
penetration and investor interest.
Recommended Next Steps:
Conduct comprehensive interviews with health professionals and patients.
Develop effective co-branding campaigns with JRAH.
Implement iterations of MVP based on pilot results.
Prepare investor presentations focusing on validated outcomes.
Additional Insights: Leveraging emotional pain points and offering transparent pricing as well as
cost reductions can enhance both user and investor interest, laying the groundwork for successful
scaling.
2 OF 2